36 studies found for:    primary-progressive multiple sclerosis
Show Display Options
Rank Status Study
21 Recruiting A Phase 2b/3 Study to Compare Efficacy and Safety of Masitinib to Placebo in the Treatment of Patients With Primary Progressive or Relapse-free Secondary Progressive Multiple Sclerosis
Conditions: Multiple Sclerosis, Secondary Progressive;   Multiple Sclerosis, Primary Progressive;   Multiple Sclerosis, Relapse Free
Interventions: Drug: masitinib;   Drug: placebo
22 Completed Correlation Between Multiple Sclerosis Functional Composite (MSFC) and Expanded Disability Status Scale (EDSS) in Patients With Multiple Sclerosis (MS) in Argentina
Condition: Multiple Sclerosis
Intervention:
23 Recruiting Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
Conditions: Multiple Sclerosis, Primary Progressive;   Multiple Sclerosis, Secondary Progressive
Interventions: Drug: ibudilast;   Drug: Placebo
24 Completed Neurophysiological Study of Sativex in Multiple Sclerosis (MS) Spasticity
Condition: Multiple Sclerosis
Interventions: Drug: Sativex®;   Drug: Placebo
25 Unknown  Cannabis for Spasticity in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Smoked Cannabis;   Drug: Smoked Cannabis and oral marinol;   Drug: Placebo
26 Terminated Cannabis for Spasticity in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Smoked Cannabis
27 Active, not recruiting Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease
Conditions: Multiple Sclerosis (MS);   Relapsing-Remitting MS;   Primary Progressive MS;   Secondary Progressive MS;   Clinically Isolated Syndrome (CIS)
Intervention: Other: No study treatments administered - blood draws only
28 Recruiting A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis
Conditions: Multiple Sclerosis, Remittent Progressive;   Multiple Sclerosis, Primary Progressive;   Relapsing-Remitting Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis;   Multiple Sclerosis
Interventions: Drug: Placebo;   Drug: fampridine (BIIB041)
29 Recruiting Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis
Conditions: Relapsing Remitting MS;   Secondary Progressive MS;   Primary Progressive MS
Interventions: Dietary Supplement: Caprylic Triglyceride;   Dietary Supplement: Placebo
30 Recruiting Prognosis Value of the Neuronal Damage in Early Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: PET with 11C-Flumazenil
31 Unknown  Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients
Conditions: Relapsing Remitting Multiple Sclerosis;   Multiple Sclerosis, Chronic Progressive
Intervention: Drug: Ritalin
32 Completed Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Daclizumab
33 Recruiting Using Optical Coherence Tomography to Capture Retinal Microvascular Changes Associated With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
34 Recruiting Quantified Balance Measures During Stance and Gait: Multiple Sclerosis Patients. A Longitudinal Clinical Study
Condition: Balance Control
Intervention:
35 Completed Physical Disability in Patients Treated With Betaferon
Condition: Multiple Sclerosis
Intervention: Drug: Interferon-1beta (Betaseron, BAY86-5046)
36 Recruiting Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene Mutation
Condition: Amyotrophic Lateral Sclerosis
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-36) Next Page
Indicates status has not been verified in more than two years